XML 55 R42.htm IDEA: XBRL DOCUMENT v3.22.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
SUMMARY OF STOCK OPTIONS OUTSTANDING

Activity in the various Plans during the years ended December 31, 2021 and 2020 is reflected in the following table:

 

Options  Number of
Shares
   Weighted
Average
Exercise Price
 
Outstanding at January 1, 2020   589,125   $3.74 
Granted   255,000    2.09 
Exercised   (1,875)   4.16 
Forfeited   (3,937)   (12.14)
Outstanding at December 31, 2020   838,313   $3.20 
Exercisable at December 31, 2020   725,813   $3.37 

 

Options  Number of
Shares
   Weighted
Average
Exercise Price
 
Outstanding at January 1, 2021   838,313   $3.20 
Granted   300,000    1.67 
Exercised        
Forfeited   (52,250)   (11.61)
Outstanding at December 31, 2021   1,086,063   $2.37 
Exercisable at December 31, 2021   936,063   $2.48 
SCHEDULE OF FAIR VALUE OF STOCK OPTIONS ASSUMPTION

The Company has utilized the following assumptions in its Black-Scholes option valuation model to calculate the estimated grant date fair value of the options during the years ended December 31, 2021 and 2020:

 

   2021   2020 
   Assumptions   Assumptions 
Volatility – range   113%   104%
Risk-free rate   1.30%   0.28%
Expected term   10.0 years    5.5 years 
Exercise price  $1.67   $2.09 
SCHEDULE OF SHARES AUTHORIZED UNDER STOCK OPTION PLANS BY EXERCISE PRICE RANGE

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of December 31, 2021:

 

    Outstanding options   Exercisable options 
Exercise price
range
   Number of
options
   Weighted
average
remaining
contractual life
   Number of
options
   Weighted average
remaining
contractual life
 
                  
$0.01 to $2.49    715,000    8.6 years    565,000    8.3 years 
$2.50 to $3.49    310,313    6.3 years    310,313    6.3 years 
$3.50 to $4.49    45,750    3.1 years    45,750    3.1 years 
$4.50 to $6.99    15,000    0.1 years    15,000    0.1 years 
                       
      1,086,063    7.6 years    936,063    7.3 years 
SUMMARY OF RESTRICTED STOCK ACTIVITY

A summary of all restricted stock activity under the equity compensation plans for the years ended December 31, 2021 and 2020 is as follows:

 

   Number of
Restricted
shares
   Weighted
average
grant date
fair value
 
Nonvested balance, January 1, 2020   514,875   $2.97 
Granted   846,591    1.02 
Vested   (604,591)   (1.85)
Forfeited   (36,750)   (1.84)
Nonvested balance, December 31, 2020   720,125   $1.69 

 

   Number of
Restricted
shares
   Weighted
average
grant date
fair value
 
Nonvested balance, January 1, 2021   720,125   $1.69 
Granted   856,000    2.07 
Vested   (511,250)   (1.94)
Forfeited   (7,500)   (1.08)
Nonvested balance, December 31, 2021   1,057,375   $1.87 
SCHEDULE OF NON-VESTED BALANCE OF RESTRICTED STOCK

The nonvested balance of restricted stock vests as follows:

 

Years ended  Number of
shares
 
     
2022   585,375 
2023   358,000 
2024   54,000 
2025   30,000 
2026   30,000